首页 | 本学科首页   官方微博 | 高级检索  
     

沙利度胺联合化疗治疗难治性多发性骨髓瘤
引用本文:关建民. 沙利度胺联合化疗治疗难治性多发性骨髓瘤[J]. 菏泽医学专科学校学报, 2010, 22(3): 4-6. DOI: 10.3969/j.issn.1008-4118.2010.03.02
作者姓名:关建民
作者单位:菏泽医学专科学校,山东,菏泽,274030
摘    要:
目的探讨沙利度胺联合化疗治疗难治性多发性骨髓瘤难治性多发性骨髓瘤的疗效方法52例难治性多发性骨髓瘤患者接受沙利度胺联合化疗3个以上疗程。以骨髓瘤细胞和M蛋白比例、血红蛋白、血钙等定量作为治疗前后观察指标。结果52例难治性多发性骨髓瘤完全缓解6例,部分缓解14例,进步24例,未缓解8例,总有效率84.6%。结论沙利度胺联合化学治疗难治性多发性骨髓瘤疗效明显,不良作用小,耐受性较好。

关 键 词:沙利度胺/治疗应用  难治性多发性骨髓瘤/治疗

Thalidomide plus united-chemotherapy in treatment of multiple myeloma
GUAN Jian-min. Thalidomide plus united-chemotherapy in treatment of multiple myeloma[J]. Journal of Heze Medical College, 2010, 22(3): 4-6. DOI: 10.3969/j.issn.1008-4118.2010.03.02
Authors:GUAN Jian-min
Affiliation:GUAN Jian-min (Heze Medical School,Shan Dong,Heze,274030)
Abstract:
Objective To observe the treatment effect of Thalidomide plus united-chemotherapy in treatment of multiple myeloma(MM).Methods fifty-two patients with Thalidomide plus united-chemotherapy were treated for 3 course of treatment,using myeloma cell amd M protein,cruorin,blood calcium as observation target in pre-treatment and post-treatment.Results In thirty effective patients,about 6 patients gained complete response(CR),14 patients gained partial response(PR),24 patients gained improve(I),8 patients unreliev...
Keywords:Thalidomide  refractory multiple mythloma  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号